GYGuangwen Yang

Guangwen Yang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Guangwen Yang has a total of 18 co-authors. Here are the top co-authors by number of shared publications:

  • Heng Dong

    Nanjing Stomatological Hospital Affiliated Hospital of Medical School Institute of Stomatology Nanjing University Nanjing China

    4 shared publications
  • Yongbin Mou

    Nanjing Stomatological Hospital, Affiliated Hospital of Medical School, Institute of Stomatology, Nanjing University, 30 Zhongyang Road, Nanjing, Jiangsu 210008, China

    4 shared publications
  • Li Chen

    Department of Oral Implantology, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing, Jiangsu, China

    2 shared publications
  • Haohao Huang

    Department of Oral and Maxillofacial Surgery, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing, Jiangsu, People’s Republic of China

    1 shared publication
  • Hui Liu

    Department of Oral Implantology, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing,Jiangsu, People’s Republic of China

    1 shared publication
  • Hui Liu

    Department of Pathology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou, China

    1 shared publication

Latest Publications

  • An Exploratory Immune‐Associated Prognostic Signature and AREG‐Associated Phenotypes in Oral Squamous Cell Carcinoma

    by Shiling Dong, Jingjing Cheng, Shuanfeng Xing, Guangwen Yang

    Background: Oral squamous cell carcinoma (OSCC) remains a clinically heterogeneous malignancy with unsatisfactory long‐term outcomes, particularly in patients with advanced disease and treatment resistance. Conventional clinicopathologic parameters incompletely capture the biological diversity of OSCC and provide limited guidance for individualised therapeutic stratification. Methods: We performed an integrated transcriptomic analysis of TCGA‐derived OSCC data to construct and evaluate an immune‐associated prognostic signature. Associations with survival, clinicopathologic features, immune infiltration, somatic mutation profiles and pathway‐level biological programs were assessed. The manuscript‐specified ten‐gene equation was additionally evaluated without refitting in an independent CPTAC oral‐cavity SCC cohort using overall survival, Harrell's C‐index and time‐dependent ROC analysis. Amphiregulin (AREG) was selected for functional investigation using siRNA‐mediated knockdown, proliferation assays, cisplatin sensitivity testing, IC50 estimation and apoptosis analysis in OSCC cells. Results: The original TCGA analysis separated survival groups and reported 1‐, 3‐ and 5‐year AUCs of 0.701, 0.693 and 0.623. In 42 independent CPTAC patients with 14 deaths, however, the fixed score was not significantly associated with overall survival (HR per SD, 1.181; 95% CI, 0.674–2.069; p = 0.561). The C‐index was 0.521, and the 1‐ and 3‐year AUCs were 0.369 and 0.550; 5‐year evaluation was unsupported by follow‐up. The supplied AREG experiments suggested reduced proliferation and increased cisplatin sensitivity after knockdown. Conclusions: This study identifies an exploratory immune‐associated score and AREG‐associated cellular phenotypes in OSCC.

  • Open Access

    Mouse Tumor-Bearing Models as Preclinical Study Platforms for Oral Squamous Cell Carcinoma

    by Qiang Li, Heng Dong, Guangwen Yang, Yuxian Song, Yongbin Mou, Yanhong Ni

    Preclinical animal models of oral squamous cell carcinoma (OSCC) have been extensively studied in recent years. Investigating the pathogenesis and potential therapeutic strategies of OSCC is required to further progress in this field, and a suitable research animal model that reflects the intricacies of cancer biology is crucial. Of the animal models established for the study of cancers, mouse tumor-bearing models are among the most popular and widely deployed for their high fertility, low cost, and molecular and physiological similarity to humans, as well as the ease of rearing experimental mice. Currently, the different methods of establishing OSCC mouse models can be divided into three categories: chemical carcinogen-induced, transplanted and genetically engineered mouse models. Each of these methods has unique advantages and limitations, and the appropriate application of these techniques in OSCC research deserves our attention. Therefore, this review comprehensively investigates and summarizes the tumorigenesis mechanisms, characteristics, establishment methods, and current applications of OSCC mouse models in published papers. The objective of this review is to provide foundations and considerations for choosing suitable model establishment methods to study the relevant pathogenesis, early diagnosis, and clinical treatment of OSCC.


  • Retrospective clinical analysis of risk factors associated with failed short implants

    by Li Chen, Li Chen, Tao Yang, Tao Yang, Guangwen Yang, Guangwen Yang, Na Zhou, Na Zhou, Heng Dong, Heng Dong, et al.

    Background: With advanced technology, short implants are more commonly used and have proven to have a relatively reliable curable efficacy. A consensus has not been reached regarding potential risk factors related to the loss of short implants.Purpose: This large‐sample retrospective study concentrated not only on patient characteristics and medical procedures but also on the features of implants in order to uncover the risk factors associated with short implants.Methods: Between 2014 and 2017, a total of 7001 implants were inserted at Nanjing Stomatological Hospital, Medical School of Nanjing University. Among the all, 1236 short implants were included after being evaluated according to the inclusion and exclusion criteria. In organizing the detailed information, seven variables including bone grafting procedure, age, gender, diameter of the implant, implant position, surface treatment, and definitive restorations were taken into consideration. The χ2 test, Kaplan‐Meier test, logistic regression, and multifactorial Cox regression analysis were employed to explore the risk factors.Results: The cumulative survival rate of short implants was 96.36%, slightly lower than that of the standard implants (98.16%, P < .001). Most of the short implants (84.44%) were lost at the early stage, mainly because of infection. Based on the results, male gender, implants treated by titanium anodizing and single‐crown restoration increased the loss rate of short implants. Comparison of the short implants inserted into the maxillary and mandibular posterior area alone showed that the maxillary molar area was a risk factor for prognosis.Conclusions: Male gender, TA surface treatment, and the presence of a single crown were associated with an increasing rate of short implants loss. Examination of the implant location focused on the posterior area revealed the maxillary posterior area to be a risk factor.


  • Risk factors and reoperative survival rate of failed narrow‐diameter implants in the maxillary anterior region

    by Guangwen Yang, Li Chen, Ying Gao, Hui Liu, Heng Dong, Yongbin Mou

    Background Narrow‐diameter implants (NDIs) have been proposed to address the dilemma of implant installation in cases of insufficient bone volume. However, the potential risk factors of failed NDIs, and whether reimplants with reliable efficacy are still controversial. Purpose This study aimed to evaluate the survival/success rate of NDIs in the maxillary anterior region and that of reimplants at the same site, as well as to explore the potential risk factors of original and replaced implants. Materials and Methods From January 2015 to April 2019, patients receiving NDIs in the anterior maxilla were enrolled in the present study. Multiple variables were assessed to exploit the risk factor of failed NDIs, including age, sex, implant sites, length, surface characteristics, and healing abutment designs. The relationship between bone augmentation and the number of missing teeth was assessed. For failed NDIs, the reasons for NDIs removal and marginal bone loss (MBL) were analyzed. The details and outcomes of reimplants were evaluated. Results Cumulative survival rates (CSRs) and success rates of 1095 NDIs installed in 835 patients were 96.99% and 96.51%, respectively. In total, 33 of these NDIs failed. TiUnite (TU) surface was a risk factor and it affected the success rate (92.56%) and CSR (92.4%) of NDIs (P < .001). The single NDIs with bone augmentation have lower failure rate. The average MBL for 33 failed NDIs was 1.92 ± 1.91 mm. Additionally, 22 patients with 23 NDIs accepted reimplantation of previously failed NDIs, and the success rate of reimplants was 95.65%. Conclusions Surface characteristic (TU surface) was a risk factor for failure of NDIs in the maxillary anterior region. Bone augmentation simultaneously performed during NDIs implantation was favorable for a single missing tooth. As an alternative plan, the reimplantation of failed NDIs was reliable and stable after successful bone reconstruction.


  • Open Access

    Satisfaction analysis of patients with single implant treatments based on a questionnaire survey

    by Heng Dong, Na Zhou, Hui Liu, Haohao Huang, Guangwen Yang, Li Chen, Meng Ding, Yongbin Mou

    Background: The factors influencing satisfaction of the patients with implant treatments are still unclear. This study aims to evaluate the patients’ satisfaction and to identify influencing factors, which will improve the medical quality of oral implantology. Materials and methods: Patients who lost single teeth and received implant treatments were enrolled in Nanjing Stomatological Hospital between February 2016 and March 2018. A questionnaire survey was performed to assess patient satisfaction and data were collected at four time points. Information included gender, age, educational level, application of bone augmentation, type of prosthetic restoration, period of teeth loss, dentist qualification, and tooth position. Meanwhile, the satisfaction of the patients was evaluated by visual analog scale. Results: A total of 373 patients completed the questionnaires. The mean of overall satisfaction score was 69.05±7.10. Lower overall satisfaction score was found in patients who received bone augmentation (PPPPPPPConclusion: Bone augmentation and the period of teeth loss are negative factors affecting patient satisfaction, and the success rate and survival time of implants are considerable aspects for patients. It is essential to raise general awareness of oral hygiene and optimize the dental implant therapeutic process.